Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea
· Delayed Price · Currency is KRW 87,000
-400 (-0.46%)
At close: Dec 5, 2025
KRX:185750 Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Operating Revenue | 1,680,988 | 1,586,431 | 1,669,404 | 1,488,345 | 1,343,559 | 1,303,006 | Upgrade
|
| Other Revenue | - | -0 | - | - | - | - | Upgrade
|
| Revenue | 1,680,988 | 1,586,431 | 1,669,404 | 1,488,345 | 1,343,559 | 1,303,006 | Upgrade
|
| Revenue Growth (YoY) | 0.32% | -4.97% | 12.16% | 10.78% | 3.11% | 20.72% | Upgrade
|
| Cost of Revenue | 1,154,547 | 1,053,820 | 1,007,203 | 945,705 | 847,741 | 813,866 | Upgrade
|
| Gross Profit | 526,441 | 532,611 | 662,202 | 542,639 | 495,818 | 489,140 | Upgrade
|
| Selling, General & Admin | 274,667 | 267,793 | 256,595 | 237,936 | 220,982 | 202,292 | Upgrade
|
| Research & Development | 165,741 | 143,914 | 140,235 | 176,325 | 163,277 | 146,664 | Upgrade
|
| Amortization of Goodwill & Intangibles | 3,892 | 3,080 | 2,169 | 1,926 | 1,794 | 1,982 | Upgrade
|
| Other Operating Expenses | 12,467 | 12,605 | 11,694 | 11,387 | 12,206 | 10,184 | Upgrade
|
| Operating Expenses | 462,593 | 433,150 | 415,602 | 432,733 | 401,060 | 365,204 | Upgrade
|
| Operating Income | 63,848 | 99,462 | 246,599 | 109,906 | 94,759 | 123,936 | Upgrade
|
| Interest Expense | -7,012 | -8,319 | -9,271 | -6,847 | -4,030 | -3,871 | Upgrade
|
| Interest & Investment Income | 8,374 | 12,691 | 6,028 | 2,333 | 759.37 | 1,387 | Upgrade
|
| Earnings From Equity Investments | - | - | 798.36 | -460.38 | -603.47 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -1,315 | 2,918 | -2,356 | -2,524 | -183.41 | -569.56 | Upgrade
|
| Other Non Operating Income (Expenses) | -108.34 | -1,208 | -1,777 | 838.33 | -10,128 | 371.38 | Upgrade
|
| EBT Excluding Unusual Items | 63,787 | 105,543 | 240,021 | 103,246 | 80,573 | 121,253 | Upgrade
|
| Gain (Loss) on Sale of Investments | -3,514 | -2,764 | 1,465 | -2,223 | -98.87 | 517.38 | Upgrade
|
| Gain (Loss) on Sale of Assets | 59.44 | 154 | 111.88 | 54.05 | 119.34 | 68.18 | Upgrade
|
| Asset Writedown | -56.24 | -923.8 | - | -3,912 | - | - | Upgrade
|
| Pretax Income | 60,277 | 102,009 | 241,598 | 97,165 | 80,594 | 121,839 | Upgrade
|
| Income Tax Expense | 675.97 | -9,433 | 27,996 | 17,187 | 38,237 | 31,434 | Upgrade
|
| Earnings From Continuing Operations | 59,601 | 111,442 | 213,602 | 79,978 | 42,356 | 90,405 | Upgrade
|
| Minority Interest in Earnings | -358.27 | -2,369 | -1,081 | 975.58 | 363.91 | 1,228 | Upgrade
|
| Net Income | 59,242 | 109,073 | 212,521 | 80,953 | 42,720 | 91,633 | Upgrade
|
| Net Income to Common | 59,242 | 109,073 | 212,521 | 80,953 | 42,720 | 91,633 | Upgrade
|
| Net Income Growth | -68.66% | -48.68% | 162.52% | 89.50% | -53.38% | 70.06% | Upgrade
|
| Shares Outstanding (Basic) | 13 | 13 | 14 | 13 | 14 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 13 | 13 | 14 | 13 | 14 | 14 | Upgrade
|
| Shares Change (YoY) | -5.39% | -5.20% | 3.79% | -1.77% | -0.73% | -0.06% | Upgrade
|
| EPS (Basic) | 4500.71 | 8234.46 | 15210.37 | 6013.65 | 3117.38 | 6637.55 | Upgrade
|
| EPS (Diluted) | 4500.71 | 8234.46 | 15210.37 | 6013.65 | 3117.38 | 6637.55 | Upgrade
|
| EPS Growth | -66.87% | -45.86% | 152.93% | 92.91% | -53.03% | 70.17% | Upgrade
|
| Free Cash Flow | -123,894 | 25,815 | 276,942 | 22,836 | -35,339 | 71,684 | Upgrade
|
| Free Cash Flow Per Share | -9412.36 | 1948.91 | 19821.04 | 1696.38 | -2578.75 | 5192.55 | Upgrade
|
| Dividend Per Share | 1100.000 | 1100.000 | - | - | - | - | Upgrade
|
| Gross Margin | 31.32% | 33.57% | 39.67% | 36.46% | 36.90% | 37.54% | Upgrade
|
| Operating Margin | 3.80% | 6.27% | 14.77% | 7.38% | 7.05% | 9.51% | Upgrade
|
| Profit Margin | 3.52% | 6.88% | 12.73% | 5.44% | 3.18% | 7.03% | Upgrade
|
| Free Cash Flow Margin | -7.37% | 1.63% | 16.59% | 1.53% | -2.63% | 5.50% | Upgrade
|
| EBITDA | 107,713 | 139,234 | 283,629 | 143,504 | 122,241 | 147,721 | Upgrade
|
| EBITDA Margin | 6.41% | 8.78% | 16.99% | 9.64% | 9.10% | 11.34% | Upgrade
|
| D&A For EBITDA | 43,864 | 39,772 | 37,030 | 33,598 | 27,482 | 23,786 | Upgrade
|
| EBIT | 63,848 | 99,462 | 246,599 | 109,906 | 94,759 | 123,936 | Upgrade
|
| EBIT Margin | 3.80% | 6.27% | 14.77% | 7.38% | 7.05% | 9.51% | Upgrade
|
| Effective Tax Rate | 1.12% | - | 11.59% | 17.69% | 47.45% | 25.80% | Upgrade
|
| Advertising Expenses | - | 74,740 | 69,707 | 60,364 | 51,329 | 45,629 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.